Comments
The specialty chemical manufacturer ₹496.49-crore IPO of Rossari Biotech has been subscribed 79.37 times. Bids for 64.87 crore were received against the offering of 81.73 lakh. The QIB portion got subscribed 85.26 times, high net worth 239.83 times and retail portion subscribed 7.23 times.
Ahead of IPO, the company had raised ₹148.87 crore from marquee anchor investors such as Abu Dhabi Investment Authority, Malabar India Fund and Ashoka India Opportunities fund besides large domestic mutual fund houses. The price band for the IPO was fixed between ₹423 – 425 a share and opened for bidding on 13 July.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.